{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:26:27Z","timestamp":1782534387039,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Herpes zoster (HZ) has been reported as a potential post-viral complication in individuals recovering from COVID-19, possibly due to virus-induced immune dysregulation. We aimed to investigate whether post-COVID HZ is associated with an elevated risk of hematologic or infectious complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study using the TriNetX global research network, which aggregates de-identified electronic health records from more than 140 healthcare institutions. Adults diagnosed with COVID-19 between January 2020 and January 2022 were stratified by the presence or absence of HZ within one year of infection and matched 1:1 by age, sex, and comorbidities. Outcomes including leukopenia, urinary tract infection, multiple myeloma, and acute leukemia were evaluated over a three-year follow-up using time-to-event and multivariable Cox regression analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Individuals with post-COVID HZ had significantly higher risks of developing hematologic and infectious complications. Subgroup analyses identified older age, impaired kidney function, elevated inflammatory markers, and metabolic abnormalities as factors associated with greater risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These findings suggest that HZ following COVID-19 may serve as a clinical indicator of immune vulnerability and heightened susceptibility to hematologic and infectious disorders. Long-term monitoring may be warranted in high-risk populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1651614","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:29:03Z","timestamp":1758518943000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Chien-Lin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Liang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e28745","DOI":"10.1002\/jmv.28745","article-title":"Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2\u202f442\u202f686 patients","volume":"95","author":"Chen","year":"2023","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/vim.2022.0002","article-title":"Dysfunctional state of T cells or exhaustion during chronic viral infections and COVID-19: a review","volume":"35","author":"Mishra","year":"2022","journal-title":"Viral Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40121-024-00924-3","article-title":"The impact of the COVID-19 pandemic on the incidence of herpes zoster: a narrative literature review","volume":"13","author":"Parikh","year":"2024","journal-title":"Infect Dis Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.4103\/jfmpc.jfmpc_2112_22","article-title":"Association between COVID-19 infection and herpes zoster: a case series","volume":"12","author":"Narasimhan","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clindermatol.2013.11.010","article-title":"Herpes zoster as a systemic disease","volume":"32","author":"Staikov","year":"2014","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.47102\/annals-acadmedsg.V38N2p136","article-title":"Herpes zoster as a useful clinical marker of underlying cell-mediated immune disorders","volume":"38","author":"Soyuncu","year":"2009","journal-title":"Ann Acad Med Singap"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1093\/infdis\/jiy385","article-title":"Herpes zoster: epidemiological links with stroke and myocardial infarction","volume":"218","author":"Warren-Gash","year":"2018","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","article-title":"Herpes zoster and long-term risk of cardiovascular disease","volume":"11","author":"Curhan","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000505911","article-title":"Herpes zoster and subsequent cancer risk: a nationwide population-based cohort study in Korea","volume":"237","author":"Kim","year":"2021","journal-title":"Dermatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1158\/1055-9965.EPI-15-1033","article-title":"Herpes zoster and risk of cancer in the elderly U.S. population","volume":"25","author":"Mahale","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e20908","DOI":"10.7759\/cureus.20908","article-title":"Herpes zoster infection in an immunocompromised patient: a case report and review of corticosteroid's role","volume":"14","author":"Seixas","year":"2022","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e15521","DOI":"10.1111\/dth.15521","article-title":"Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination","volume":"35","author":"Almutairi","year":"2022","journal-title":"Dermatol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"710217","DOI":"10.3389\/fimmu.2021.710217","article-title":"Data-driven analysis of COVID-19 reveals persistent immune abnormalities in convalescent severe individuals","volume":"12","author":"Lim","year":"2021","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/10815589231158041","article-title":"The role of immune activation and antigen persistence in acute and long COVID","volume":"71","author":"Opsteen","year":"2023","journal-title":"J Investig Med"},{"key":"ref17","first-page":"e68","article-title":"Herpes zoster as a marker of underlying malignancy","volume":"7","author":"Iglar","year":"2013","journal-title":"Open Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-8790.1000192","article-title":"Bone marrow features and natural history of BCR\/ABL-positive thrombocythemia and chronic myeloid leukemia compared to BCR\/ABL negative thrombocythemia in essential thrombocythemia and polycythemia vera","volume":"3","author":"Michiels","year":"2015","journal-title":"J Hematol Thromb Dis"},{"key":"ref19","first-page":"289","article-title":"BCR-ABL positive childhood chronic myeloid leukemia","volume":"7","author":"Ekwere","year":"2017","journal-title":"J Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/08830738060210050901","article-title":"Second Malignant Neoplasms Following the Treatment of Brain Tumors in Children","volume":"21","author":"B\u00fcy\u00fckpamuk\u00e7u","year":"2006","journal-title":"J Child Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/(SICI)1096-911X(199605)26:5<359::AID-MPO9>3.0.CO;2-H","article-title":"Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia","volume":"26","author":"Polychronopoulou","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"ref22","first-page":"247","article-title":"Second malignancies in patients treated for Hodgkin's disease","volume":"46","author":"Keresztes","year":"2002","journal-title":"Magy Onkol"},{"key":"ref23","first-page":"S13","article-title":"Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence","volume":"109","author":"Oxman","year":"2009","journal-title":"J Am Osteopath Assoc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"ltab 015","DOI":"10.1093\/immadv\/ltab015","article-title":"Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact","volume":"1","author":"Zhang","year":"2021","journal-title":"Immunother Adv"},{"key":"ref25","first-page":"67","article-title":"Synergism of CD28 immune molecule in late immunosuppressive phase of COVID-19: effectiveness in vaccinated individuals","volume":"29","author":"Alharbi","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"109177","DOI":"10.1016\/j.clim.2022.109177","article-title":"Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities","volume":"245","author":"Alahdal","year":"2022","journal-title":"Clin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/jnr.24917","article-title":"A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients","volume":"99","author":"Roe","year":"2021","journal-title":"J Neurosci Res"},{"key":"ref28","first-page":"1835","article-title":"The etiology and management of leukopenia","volume":"30","author":"Ing","year":"1984","journal-title":"Can Fam Physician"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2141.2005.05462.x","article-title":"Susceptibility to infection in patients with neutropenia: the role of the innate immune system","volume":"129","author":"Neth","year":"2005","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0252206","DOI":"10.1371\/journal.pone.0252206","article-title":"Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction","volume":"16","author":"Belok","year":"2021","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune Dysfunction and Risk of Infection in Chronic Kidney Disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/tid.12534","article-title":"Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections","volume":"18","author":"Crepin","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2022.12.001","article-title":"Clonal hematopoiesis and inflammation - the perpetual cycle","volume":"33","author":"Avagyan","year":"2023","journal-title":"Trends Cell Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminhematol.2024.01.012","article-title":"Clonal hematopoiesis and autoimmunity","volume":"61","author":"Kishtagari","year":"2024","journal-title":"Semin Hematol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"107038","DOI":"10.1016\/j.leukres.2023.107038","article-title":"From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers","volume":"127","author":"Gurnari","year":"2023","journal-title":"Leuk Res"},{"key":"ref37","first-page":"65","article-title":"Tumor necrosis factor is a survival and proliferation factor for human myeloma cells","volume":"10","author":"Jourdan","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.leu.2404229","article-title":"Inflammation and multiple myeloma: the Toll connection","volume":"20","author":"Mantovani","year":"2006","journal-title":"Leukemia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1852517","article-title":"Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma","volume":"2017","author":"Musolino","year":"2017","journal-title":"Mediat Inflamm"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12026-014-8528-x","article-title":"Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma","volume":"59","author":"Rosean","year":"2014","journal-title":"Immunol Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41408-021-00588-z","article-title":"Impact of COVID-19 in patients with multiple myeloma based on a global data network","volume":"11","author":"Martinez-Lopez","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41408-023-00795-w","article-title":"Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic","volume":"13","author":"Carmichael","year":"2023","journal-title":"Blood Cancer J"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.clml.2023.01.006","article-title":"Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)","volume":"23","author":"Ehsan","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/bjc.2017.124","article-title":"Herpes zoster risk after 21 specific cancers: population-based case-control study","volume":"116","author":"Hansson","year":"2017","journal-title":"Br J Cancer"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.11604\/pamj.2021.39.117.30000","article-title":"Multiple myeloma remission following COVID-19: an observation in search of a mechanism (a case report)","volume":"39","author":"Antwi-Amoabeng","year":"2021","journal-title":"Pan Afr Med J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/ced\/llae176","article-title":"Immune reconstitution is the trigger of herpes zoster with lymphopenia and high neutrophil-to-lymphocyte ratio in a retrospective cohort study","volume":"49","author":"Yamamoto","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-021-00296-9","article-title":"Dysregulated hematopoiesis in bone marrow marks severe COVID-19","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00018-022-04220-6","article-title":"Hematopoietic responses to SARS-CoV-2 infection","volume":"79","author":"Elahi","year":"2022","journal-title":"Cell Mol Life Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1651614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:29:05Z","timestamp":1758518945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1651614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":48,"alternative-id":["10.3389\/fmed.2025.1651614"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1651614","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"article-number":"1651614"}}